Expansion of West Coast Presence:
HCR has appointed Matthew H. Bullard as a Managing Director based in San Francisco, CA.
“We are very pleased to welcome Matt to the HCR team,” said Clarke B. Futch, Chief Executive Officer and Chairman at HCR. “With over two decades of healthcare experience, Matt brings a wealth of knowledge and relationships to HCR. Matt will round out HCR’s team on the West Coast, which has been one of our most important markets. Matt’s addition along with HCR’s existing professionals on the West Coast, Sean Mansoory, Mardi Dier (Senior Advisor) and Gary Lyons (Senior Advisor), demonstrates HCR’s commitment to its regional model and provides the firm with more scale and depth to better serve the needs of biopharmaceutical companies in that region.”
Date Time
Nanodroplets and Ultrasound ‘Drills’ Prove Effective at Tackling Tough Blood Clots
Engineering researchers have developed a new technique for eliminating particularly tough blood clots, using engineered nanodroplets and an ultrasound “drill” to break up the clots from the inside out. The technique has not yet gone through clinical testing. In vitro testing has shown promising results.
Specifically, the new approach is designed to treat retracted blood clots, which form over extended periods of time and are especially dense. These clots are particularly difficult to treat because they are less porous than other clots, making it hard for drugs that dissolve blood clots to penetrate into the clot.
Parkridge Health System Names Will Windham CEO Of Parkridge East Hospital Thursday, January 7, 2021
Parkridge Health System has named Will Windham as new CEO of Parkridge East Hospital.
Officials said, Having served in progressive leadership roles since 2006 across Parkridge Health parent company HCA Healthcare, Windham is poised to make an immediate impact on Parkridge East, spurring the hospital’s growth initiatives – notably an expansion of The Birth Place that is currently underway.
“Will has an exceptional track record for catalyzing service line growth that makes him a perfect fit for Parkridge East,” said Tom Ozburn, president and CEO of Parkridge Health. “The strong leadership skills he has demonstrated throughout his career will be integral to operationalizing our plans for expansion at Parkridge East. We couldn’t be more pleased to welcome him to the Parkridge Health family.”
This contest is closed. Please check back in mid-May 2021!
The Malahat Review invites creative nonfiction writers to enter the Constance Rooke Creative Nonfiction Prize, for which one prize of
$CAN 1,000 is awarded. The contest is open to Canadian and international writers anywhere in the world, with a final deadline of 11:59pm (PDT) on 5 August 2020. All entries are judged anonymously, and the winning piece will be published in the magazine s winter issue #213. The Constance Rooke Creative Nonfiction Prize is awarded to the best work submitted to the magazine’s annual contest for a genre that embraces, but is not limited to, the personal essay, memoir, narrative nonfiction, social commentary, travel writing, historical accounts, and biography, all enhanced by such elements as description, dramatic scenes, dialogue, and characterization.